Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01)
Phase 1, Double Blind, Randomized, Parallel-Group, Single-Dose, 3-Arm, Comparative Pharmacokinetic Study Of PF-06439535 And Bevacizumab Sourced From US And EU Administered To Healthy Male Volunteers
Status: Enrolling
Updated:  4/3/2014
Pfizer Investigational Site
mi
from
South Miami, FL
A Pharmacokinetic Study Comparing PF-06439535 And Bevacizumab In Healthy Male Volunteers (REFLECTIONS B739-01)
Phase 1, Double Blind, Randomized, Parallel-Group, Single-Dose, 3-Arm, Comparative Pharmacokinetic Study Of PF-06439535 And Bevacizumab Sourced From US And EU Administered To Healthy Male Volunteers
Status: Enrolling
Updated: 4/3/2014
Pfizer Investigational Site
mi
from
South Miami, FL
Click here to add this to my saved trials
A Study To Investigate Palbociclib (PD-0332991) Pharmacokinetics In Healthy Subjects Of Japanese Descent Relative To Healthy Non-Asian Subjects, And To Determine If Changes In Palbociclib Dose Result In Proportional Changes In Palbociclib Plasma Exposure In Japanese Subjects
A Phase 1, Open Label Study To Investigate The Effect Of Dose And Ethnicity On Palbociclib (PD-0332991) Pharmacokinetics In Japanese Healthy Volunteers
Status: Enrolling
Updated:  4/3/2014
Pfizer Investigational Site
mi
from
New Haven, CT
A Study To Investigate Palbociclib (PD-0332991) Pharmacokinetics In Healthy Subjects Of Japanese Descent Relative To Healthy Non-Asian Subjects, And To Determine If Changes In Palbociclib Dose Result In Proportional Changes In Palbociclib Plasma Exposure In Japanese Subjects
A Phase 1, Open Label Study To Investigate The Effect Of Dose And Ethnicity On Palbociclib (PD-0332991) Pharmacokinetics In Japanese Healthy Volunteers
Status: Enrolling
Updated: 4/3/2014
Pfizer Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
Relative Bioavailability For Palbociclib Formulations
A Phase 1, Open-Label, 6 Sequence, 3 Period, Crossover Study Of Palbociclib (PD-0332991) In Healthy Volunteers To Estimate The Relative Bioavailability Of 3 Palbociclib Formulations
Status: Enrolling
Updated:  4/4/2014
Pfizer Investigational Site
mi
from
New Haven, CT
Relative Bioavailability For Palbociclib Formulations
A Phase 1, Open-Label, 6 Sequence, 3 Period, Crossover Study Of Palbociclib (PD-0332991) In Healthy Volunteers To Estimate The Relative Bioavailability Of 3 Palbociclib Formulations
Status: Enrolling
Updated: 4/4/2014
Pfizer Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
A Phase I Study of AG-348 in Healthy Volunteers
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Safety, Pharmacokinetic and Pharmacodynamic Study of Orally Administered AG-348 in Healthy Volunteers
Status: Enrolling
Updated:  4/4/2014
Clinical Research Facility
mi
from
Baltimore, MD
A Phase I Study of AG-348 in Healthy Volunteers
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Safety, Pharmacokinetic and Pharmacodynamic Study of Orally Administered AG-348 in Healthy Volunteers
Status: Enrolling
Updated: 4/4/2014
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study to Evaluate the PK, Relative Bioavailability and Safety of TG-2349 With Single Oral Dose Under Fed Condition in Healthy Volunteers
A Phase 1, Randomized, Open-label, 2-way Crossover Study in Healthy East Asian and Caucasian Volunteers to Evaluate the Relative Bioavailability of A New Capsule Formulation of TG-2349 Compared to the Original Formulation of TG-2349 Oral Solution
Status: Enrolling
Updated:  4/6/2014
WCCT
mi
from
Cypress, CA
Study to Evaluate the PK, Relative Bioavailability and Safety of TG-2349 With Single Oral Dose Under Fed Condition in Healthy Volunteers
A Phase 1, Randomized, Open-label, 2-way Crossover Study in Healthy East Asian and Caucasian Volunteers to Evaluate the Relative Bioavailability of A New Capsule Formulation of TG-2349 Compared to the Original Formulation of TG-2349 Oral Solution
Status: Enrolling
Updated: 4/6/2014
WCCT
mi
from
Cypress, CA
Click here to add this to my saved trials
First-in-human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of CC-90001
A Phase 1, Randomized, Two-part Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of CC-90001 in Healthy Subjects
Status: Enrolling
Updated:  4/7/2014
PPD Development, LP
mi
from
Austin, TX
First-in-human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of CC-90001
A Phase 1, Randomized, Two-part Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of CC-90001 in Healthy Subjects
Status: Enrolling
Updated: 4/7/2014
PPD Development, LP
mi
from
Austin, TX
Click here to add this to my saved trials
Strength and Balance in Gender- and Age-Matched Controls
Strength and Balance in Gender- and Age-Matched Controls: SubStudy to "The Effects of Vitamin D on Balance in Parkinson's Disease"
Status: Enrolling
Updated:  4/8/2014
Oregon Health and Science University
mi
from
Portland, OR
Strength and Balance in Gender- and Age-Matched Controls
Strength and Balance in Gender- and Age-Matched Controls: SubStudy to "The Effects of Vitamin D on Balance in Parkinson's Disease"
Status: Enrolling
Updated: 4/8/2014
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
A Safety and Pharmacokinetics Study of CNTO 3157 in Healthy Japanese and Caucasian Participants
A Phase 1 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics and Safety of CNTO3157 Following an Escalating Single SC Dose to Healthy Japanese and Caucasian Subjects or a Single Intravenous Dose to Healthy Caucasian Subjects
Status: Enrolling
Updated:  4/9/2014
Clinical Research Facility
mi
from
Cypress, CA
A Safety and Pharmacokinetics Study of CNTO 3157 in Healthy Japanese and Caucasian Participants
A Phase 1 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Pharmacokinetics and Safety of CNTO3157 Following an Escalating Single SC Dose to Healthy Japanese and Caucasian Subjects or a Single Intravenous Dose to Healthy Caucasian Subjects
Status: Enrolling
Updated: 4/9/2014
Clinical Research Facility
mi
from
Cypress, CA
Click here to add this to my saved trials
Very Low Density Lipoprotein Turnover in Young and Elderly Individuals
Very Low Density Lipoprotein Turnover in Young and Elderly Individuals
Status: Enrolling
Updated:  4/10/2014
University of Texas Medical Branch, Dept of Surgery
mi
from
Galveston, TX
Very Low Density Lipoprotein Turnover in Young and Elderly Individuals
Very Low Density Lipoprotein Turnover in Young and Elderly Individuals
Status: Enrolling
Updated: 4/10/2014
University of Texas Medical Branch, Dept of Surgery
mi
from
Galveston, TX
Click here to add this to my saved trials
A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components
A Single-Dose, Open-Label, Randomized, 3-Way Crossover Pivotal Study to Assess the Bioequivalence of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) (2 x 50 mg/500 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin XR Tablet (2 x 500 mg) in Healthy Fed Subjects
Status: Enrolling
Updated:  4/11/2014
Clinical Research Facility
mi
from
Tempe, AZ
A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components
A Single-Dose, Open-Label, Randomized, 3-Way Crossover Pivotal Study to Assess the Bioequivalence of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) (2 x 50 mg/500 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin XR Tablet (2 x 500 mg) in Healthy Fed Subjects
Status: Enrolling
Updated: 4/11/2014
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components
A Single-Dose, Open-Label, Randomized, 3-Way Crossover Pivotal Study to Assess the Bioequivalence of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) (2 x 150 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 300 mg) and Metformin XR Tablet (4 x 500 mg) in Healthy Fed Subjects
Status: Enrolling
Updated:  4/11/2014
Clinical Research Facility
mi
from
Tempe, AZ
A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components
A Single-Dose, Open-Label, Randomized, 3-Way Crossover Pivotal Study to Assess the Bioequivalence of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) (2 x 150 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 300 mg) and Metformin XR Tablet (4 x 500 mg) in Healthy Fed Subjects
Status: Enrolling
Updated: 4/11/2014
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants
A Single-Dose, Open-Label, Randomized, 3-Way Crossover Pivotal Study to Assess the Bioequivalence of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) (2 x 50 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin XR Tablet (4 x 500 mg) in Healthy Fed Subjects
Status: Enrolling
Updated:  4/11/2014
Clinical Research Facility
mi
from
Tempe, AZ
A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed Participants
A Single-Dose, Open-Label, Randomized, 3-Way Crossover Pivotal Study to Assess the Bioequivalence of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) (2 x 50 mg/1,000 mg) With Respect to the Individual Components of Canagliflozin (1 x 100 mg) and Metformin XR Tablet (4 x 500 mg) in Healthy Fed Subjects
Status: Enrolling
Updated: 4/11/2014
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
Study Evaluating Effects of Multiple-Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non-Obese and Obese Postmenopausal Women
A Phase 1, Open Label, Two Period, Fixed Sequence, Parallel Group Study to Estimate the Effects of Multiple Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non Obese (BMI <30 Kg/m2) and Obese (BMI ≥30 Kg/m2) Postmenopausal Women
Status: Enrolling
Updated:  4/17/2014
Pfizer Investigational Site
mi
from
Miami, FL
Study Evaluating Effects of Multiple-Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non-Obese and Obese Postmenopausal Women
A Phase 1, Open Label, Two Period, Fixed Sequence, Parallel Group Study to Estimate the Effects of Multiple Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non Obese (BMI <30 Kg/m2) and Obese (BMI ≥30 Kg/m2) Postmenopausal Women
Status: Enrolling
Updated: 4/17/2014
Pfizer Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Study Evaluating Effects of Multiple-Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non-Obese and Obese Postmenopausal Women
A Phase 1, Open Label, Two Period, Fixed Sequence, Parallel Group Study to Estimate the Effects of Multiple Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non Obese (BMI <30 Kg/m2) and Obese (BMI ≥30 Kg/m2) Postmenopausal Women
Status: Enrolling
Updated:  4/17/2014
Pfizer Investigational Site
mi
from
Miami, FL
Study Evaluating Effects of Multiple-Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non-Obese and Obese Postmenopausal Women
A Phase 1, Open Label, Two Period, Fixed Sequence, Parallel Group Study to Estimate the Effects of Multiple Dose Administration of Itraconazole on the Single Dose Pharmacokinetics of Conjugated Estrogens/Bazedoxifene in Non Obese (BMI <30 Kg/m2) and Obese (BMI ≥30 Kg/m2) Postmenopausal Women
Status: Enrolling
Updated: 4/17/2014
Pfizer Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food
A Phase 1, Open-Label, 3-Period Crossover Study Of The Effect Of An Antacid, A Proton Pump Inhibitor And An H2-Receptor Antagonist On Palbociclib (PD-0332991) Bioavailability Under Fed Conditions In Healthy Volunteers
Status: Enrolling
Updated:  4/22/2014
Pfizer Investigational Site
mi
from
New Haven, CT
Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food
A Phase 1, Open-Label, 3-Period Crossover Study Of The Effect Of An Antacid, A Proton Pump Inhibitor And An H2-Receptor Antagonist On Palbociclib (PD-0332991) Bioavailability Under Fed Conditions In Healthy Volunteers
Status: Enrolling
Updated: 4/22/2014
Pfizer Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
First-in-Human Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of Janus Kinase-1 Inhibitor PF-04965842 in Healthy Western and Japanese Subjects
A Phase 1, Within Cohort, Randomized, Double Blind, Third-Party Open, Placebo-Controlled, Single- And Multiple Dose Escalation, Parallel Group Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-04965842 In Healthy Western and Japanese Subjects
Status: Enrolling
Updated:  4/24/2014
Pfizer Investigational Site
mi
from
New Haven, CT
First-in-Human Study to Evaluate Safety and Tolerability of Single and Multiple Ascending Doses of Janus Kinase-1 Inhibitor PF-04965842 in Healthy Western and Japanese Subjects
A Phase 1, Within Cohort, Randomized, Double Blind, Third-Party Open, Placebo-Controlled, Single- And Multiple Dose Escalation, Parallel Group Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-04965842 In Healthy Western and Japanese Subjects
Status: Enrolling
Updated: 4/24/2014
Pfizer Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
The Effects of Caffeine on Force Loss Following Exercise-induced Muscle Damage
The Effects of Caffeine on Force Loss Following Exercise-induced Muscle Damage
Status: Enrolling
Updated:  4/25/2014
Sensory and Muscle Function Lab 7
mi
from
Norman, OK
The Effects of Caffeine on Force Loss Following Exercise-induced Muscle Damage
The Effects of Caffeine on Force Loss Following Exercise-induced Muscle Damage
Status: Enrolling
Updated: 4/25/2014
Sensory and Muscle Function Lab 7
mi
from
Norman, OK
Click here to add this to my saved trials
RTA 408 Lotion in Healthy Volunteers
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RTA 408 Lotion in Healthy Volunteers
Status: Enrolling
Updated:  4/28/2014
Medpace Clinical Pharmacology Unit
mi
from
Cincinnati, OH
RTA 408 Lotion in Healthy Volunteers
A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RTA 408 Lotion in Healthy Volunteers
Status: Enrolling
Updated: 4/28/2014
Medpace Clinical Pharmacology Unit
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Taste Assessment Study of SHP429 in Healthy Adult Subjects
A Phase 1, Open-label, Randomized, 3-period Crossover Taste Assessment Study to Characterize the Palatability of SHP429 When the Contents Are Sprinkled Onto Soft Foods or Emptied Into a Cup and Administered With Water in Healthy Adult Subjects
Status: Enrolling
Updated:  4/28/2014
Clinical Pharmacology of Miami
mi
from
Miami, FL
Taste Assessment Study of SHP429 in Healthy Adult Subjects
A Phase 1, Open-label, Randomized, 3-period Crossover Taste Assessment Study to Characterize the Palatability of SHP429 When the Contents Are Sprinkled Onto Soft Foods or Emptied Into a Cup and Administered With Water in Healthy Adult Subjects
Status: Enrolling
Updated: 4/28/2014
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293
A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion After Oral Administration of [14C]-AZD3293 to Healthy Male Subjects
Status: Enrolling
Updated:  4/28/2014
Covance, Inc.
mi
from
Madison, WI
A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion of [14C]-AZD3293
A Phase I, Open-Label, Single-Center Study to Assess the Absorption, Metabolism, and Excretion After Oral Administration of [14C]-AZD3293 to Healthy Male Subjects
Status: Enrolling
Updated: 4/28/2014
Covance, Inc.
mi
from
Madison, WI
Click here to add this to my saved trials
Lesinurad Tablet Bioequivalence
A Phase 1, Randomized, Open-Label, Crossover Study to Assess the Bioequivalence of Lesinurad Tablets From Two Manufacturing Sites in Healthy Adult Male Subjects
Status: Enrolling
Updated:  4/29/2014
Clinical Research Facility
mi
from
Austin, TX
Lesinurad Tablet Bioequivalence
A Phase 1, Randomized, Open-Label, Crossover Study to Assess the Bioequivalence of Lesinurad Tablets From Two Manufacturing Sites in Healthy Adult Male Subjects
Status: Enrolling
Updated: 4/29/2014
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
A Study of LY3127760 in Healthy Participants
A Single- and Multiple-Ascending Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of LY3127760 in Healthy Subjects
Status: Enrolling
Updated:  4/30/2014
Clinical Research Facility
mi
from
Evansville, IN
A Study of LY3127760 in Healthy Participants
A Single- and Multiple-Ascending Dose, Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of LY3127760 in Healthy Subjects
Status: Enrolling
Updated: 4/30/2014
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Extended Release (XR) Compared With Single Tablets
Relative Bioavailability of Two Newly Developed FDC Tablet Strengths (10 mg/1000 mg and 5mg/750mg) of Empagliflozin/Metformin Extended Release Compared With the Free Combination of Empagliflozin and Metformin Extended Release in Healthy Subjects (an Open-label, Randomised, Single Dose, Two-way Crossover Study)
Status: Enrolling
Updated:  4/30/2014
Boehringer Ingelheim Investigational Site
mi
from
Austin, TX
Relative Bioavailability of 2 Fixed Dose Combinations of Empagliflozin/Metformin Extended Release (XR) Compared With Single Tablets
Relative Bioavailability of Two Newly Developed FDC Tablet Strengths (10 mg/1000 mg and 5mg/750mg) of Empagliflozin/Metformin Extended Release Compared With the Free Combination of Empagliflozin and Metformin Extended Release in Healthy Subjects (an Open-label, Randomised, Single Dose, Two-way Crossover Study)
Status: Enrolling
Updated: 4/30/2014
Boehringer Ingelheim Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Tolerability of Single Ascending Doses of PUL-042 Inhalation Solution in Healthy Subjects
A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PUL-042 Inhalation Solution in Healthy Subjects
Status: Enrolling
Updated:  4/30/2014
ICON Development Solutions
mi
from
San Antonio, TX
Safety and Tolerability of Single Ascending Doses of PUL-042 Inhalation Solution in Healthy Subjects
A Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PUL-042 Inhalation Solution in Healthy Subjects
Status: Enrolling
Updated: 4/30/2014
ICON Development Solutions
mi
from
San Antonio, TX
Click here to add this to my saved trials
Explore the Synergy of Combination TKI Therapy
Explore the Synergy of Combination TKI Therapy - A Pilot Study to Evaluate the Effect of Imatinib on Dasatinib Pharmacokinetics in Healthy Volunteers
Status: Enrolling
Updated:  4/30/2014
Clinical Translational Science Insititute, University of Florida
mi
from
Gainesville, FL
Explore the Synergy of Combination TKI Therapy
Explore the Synergy of Combination TKI Therapy - A Pilot Study to Evaluate the Effect of Imatinib on Dasatinib Pharmacokinetics in Healthy Volunteers
Status: Enrolling
Updated: 4/30/2014
Clinical Translational Science Insititute, University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Ascending Single Doses of REGN2009 in Healthy Volunteers
Status: Enrolling
Updated:  5/5/2014
Clinical Research Facility
mi
from
Baltimore, MD
Study to Assess the Safety and Tolerability of Ascending Single Doses of REGN2009 in Healthy Volunteers
Status: Enrolling
Updated: 5/5/2014
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study to Assess the Safety and Tolerability of Ascending Single Doses of REGN2009 in Healthy Volunteers
Status: Enrolling
Updated:  5/5/2014
Clinical Research Facility
mi
from
Cincinnati, OH
Study to Assess the Safety and Tolerability of Ascending Single Doses of REGN2009 in Healthy Volunteers
Status: Enrolling
Updated: 5/5/2014
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Effect of a Hypocretin/Orexin Antagonist on Neurocognitive Performance
Effect of a Hypocretin/Orexin Antagonist on Neurocognitive Performance
Status: Enrolling
Updated:  5/6/2014
San Francisco Veterans Affairs Medical Center
mi
from
San Francisco, CA
Effect of a Hypocretin/Orexin Antagonist on Neurocognitive Performance
Effect of a Hypocretin/Orexin Antagonist on Neurocognitive Performance
Status: Enrolling
Updated: 5/6/2014
San Francisco Veterans Affairs Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Study of the Safety and Tolerability of REGN2222(SAR438584) in Healthy Adult Volunteers
Status: Enrolling
Updated:  5/13/2014
Clinical Research Facility
mi
from
Daytona Beach, FL
Study of the Safety and Tolerability of REGN2222(SAR438584) in Healthy Adult Volunteers
Status: Enrolling
Updated: 5/13/2014
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Study of the Safety and Tolerability of REGN2222(SAR438584) in Healthy Adult Volunteers
Status: Enrolling
Updated:  5/13/2014
Clinical Research Facility
mi
from
Evansville, IN
Study of the Safety and Tolerability of REGN2222(SAR438584) in Healthy Adult Volunteers
Status: Enrolling
Updated: 5/13/2014
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Study of the Safety and Tolerability of REGN2222(SAR438584) in Healthy Adult Volunteers
Status: Enrolling
Updated:  5/13/2014
Clinical Research Facility
mi
from
Dallas, TX
Study of the Safety and Tolerability of REGN2222(SAR438584) in Healthy Adult Volunteers
Status: Enrolling
Updated: 5/13/2014
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Comparison of Two Formulations of Proellex for Oral Administration
A Double-Blind Crossover Study in Healthy Volunteers to Compare Two Formulations of Proellex for Oral Administration
Status: Enrolling
Updated:  5/14/2014
Clinical Research Facility
mi
from
Houston, TX
Comparison of Two Formulations of Proellex for Oral Administration
A Double-Blind Crossover Study in Healthy Volunteers to Compare Two Formulations of Proellex for Oral Administration
Status: Enrolling
Updated: 5/14/2014
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase I Study of AG-348 in Healthy Volunteers
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Safety, Pharmacokinetic, and Pharmacodynamic Study of Orally Administered AG-348 in Healthy Volunteers
Status: Enrolling
Updated:  5/28/2014
Clinical Research Facility
mi
from
Baltimore, MD
A Phase I Study of AG-348 in Healthy Volunteers
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose, Safety, Pharmacokinetic, and Pharmacodynamic Study of Orally Administered AG-348 in Healthy Volunteers
Status: Enrolling
Updated: 5/28/2014
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects
Study of Hyperpolarized Xenon (MagniXene) in Patients With Obstructive Pulmonary Diseases (Asthma and COPD) to Assess Regional Lung Function by Delineating Regions of Abnormal Lung Ventilation
Status: Enrolling
Updated:  5/30/2014
Washington University
mi
from
St. Louis, MO
MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects
Study of Hyperpolarized Xenon (MagniXene) in Patients With Obstructive Pulmonary Diseases (Asthma and COPD) to Assess Regional Lung Function by Delineating Regions of Abnormal Lung Ventilation
Status: Enrolling
Updated: 5/30/2014
Washington University
mi
from
St. Louis, MO
Click here to add this to my saved trials
MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects
Study of Hyperpolarized Xenon (MagniXene) in Patients With Obstructive Pulmonary Diseases (Asthma and COPD) to Assess Regional Lung Function by Delineating Regions of Abnormal Lung Ventilation
Status: Enrolling
Updated:  5/30/2014
Cincinnati Children's Hospital in partnership with University Hospital of Cincinnati
mi
from
Cincinnati, OH
MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects
Study of Hyperpolarized Xenon (MagniXene) in Patients With Obstructive Pulmonary Diseases (Asthma and COPD) to Assess Regional Lung Function by Delineating Regions of Abnormal Lung Ventilation
Status: Enrolling
Updated: 5/30/2014
Cincinnati Children's Hospital in partnership with University Hospital of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects
Study of Hyperpolarized Xenon (MagniXene) in Patients With Obstructive Pulmonary Diseases (Asthma and COPD) to Assess Regional Lung Function by Delineating Regions of Abnormal Lung Ventilation
Status: Enrolling
Updated:  5/30/2014
University of Virginia
mi
from
Charlottesville, VA
MagniXene MRI Use in Patients With Asthma and COPD to Assess Regional Lung Function by Delineating Ventilation Defects
Study of Hyperpolarized Xenon (MagniXene) in Patients With Obstructive Pulmonary Diseases (Asthma and COPD) to Assess Regional Lung Function by Delineating Regions of Abnormal Lung Ventilation
Status: Enrolling
Updated: 5/30/2014
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Racial and Aging Effects of Acute Antioxidant Supplementation
Racial and Aging Effects of Acute Antioxidant Supplementation
Status: Enrolling
Updated:  6/3/2014
University of Illinois at Chicago
mi
from
Chicago, IL
Racial and Aging Effects of Acute Antioxidant Supplementation
Racial and Aging Effects of Acute Antioxidant Supplementation
Status: Enrolling
Updated: 6/3/2014
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Placebo-controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1271 in Healthy Volunteers
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Intravenous Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects
Status: Enrolling
Updated:  6/19/2014
Celerion
mi
from
Lincoln, NE
Placebo-controlled Single Dose Study to Evaluate Safety and Pharmacokinetics of GMI-1271 in Healthy Volunteers
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Intravenous Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects
Status: Enrolling
Updated: 6/19/2014
Celerion
mi
from
Lincoln, NE
Click here to add this to my saved trials
A Healthy Volunteer Study to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers
A Randomized, Double-Blind, Crossover Study in Healthy Volunteers to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers (Vifor SA and Biogen Idec OSD)
Status: Enrolling
Updated:  6/23/2014
Clinical Research Facility
mi
from
Daytona Beach, FL
A Healthy Volunteer Study to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers
A Randomized, Double-Blind, Crossover Study in Healthy Volunteers to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers (Vifor SA and Biogen Idec OSD)
Status: Enrolling
Updated: 6/23/2014
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
A Healthy Volunteer Study to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers
A Randomized, Double-Blind, Crossover Study in Healthy Volunteers to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers (Vifor SA and Biogen Idec OSD)
Status: Enrolling
Updated:  6/23/2014
Clinical Research Facility
mi
from
Evansville, IN
A Healthy Volunteer Study to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers
A Randomized, Double-Blind, Crossover Study in Healthy Volunteers to Establish the Bioequivalence of BG00012 Supplied by 2 Different Commercial Manufacturers (Vifor SA and Biogen Idec OSD)
Status: Enrolling
Updated: 6/23/2014
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
St. Jude Cancer Education for Children Program: The Feasibility of Teacher Delivery (Pilot Study)
St. Jude Cancer Education for Children Program: The Feasibility of Teacher Delivery (Pilot Study)
Status: Enrolling
Updated:  7/7/2014
St. Jude Children's Research Hospital
mi
from
Memphis, TN
St. Jude Cancer Education for Children Program: The Feasibility of Teacher Delivery (Pilot Study)
St. Jude Cancer Education for Children Program: The Feasibility of Teacher Delivery (Pilot Study)
Status: Enrolling
Updated: 7/7/2014
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Fitbit One and Text Messaging Prompts to Promote Physical Activity in Overweight/Obese Adults
Wearable Sensor/Device With Website (Fitbit One) and SMS Text Messaging Prompts to Increase Physical Activity in Overweight/Obese Adults: A Randomized Controlled Pilot Trial
Status: Enrolling
Updated:  7/11/2014
UCSD Moores Cancer Center
mi
from
La Jolla, CA
Fitbit One and Text Messaging Prompts to Promote Physical Activity in Overweight/Obese Adults
Wearable Sensor/Device With Website (Fitbit One) and SMS Text Messaging Prompts to Increase Physical Activity in Overweight/Obese Adults: A Randomized Controlled Pilot Trial
Status: Enrolling
Updated: 7/11/2014
UCSD Moores Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Adaptation in Polyphenol Bioavailability and Bioactivity During Long Term Exposure to Polyphenol-Rich Foods
Status: Enrolling
Updated:  7/22/2014
Beltsville Human Nutrition Center
mi
from
Beltsville, MD
Adaptation in Polyphenol Bioavailability and Bioactivity During Long Term Exposure to Polyphenol-Rich Foods
Status: Enrolling
Updated: 7/22/2014
Beltsville Human Nutrition Center
mi
from
Beltsville, MD
Click here to add this to my saved trials
The Effects of JNJ-42165279 on the Neural Basis of Anxiety Disorders in Healthy Male Volunteers
The Effects of JNJ-42165279 on the Neural Basis of Anxiety Disorders in Healthy Male Subjects
Status: Enrolling
Updated:  8/4/2014
Clinical Research Facility
mi
from
La Jolla, CA
The Effects of JNJ-42165279 on the Neural Basis of Anxiety Disorders in Healthy Male Volunteers
The Effects of JNJ-42165279 on the Neural Basis of Anxiety Disorders in Healthy Male Subjects
Status: Enrolling
Updated: 8/4/2014
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
A Safety, Tolerability, PD and PK Study in Healthy Adults
A Two-Part Study to Evaluate the Safety, Tolerability, Pharmacodynamics And Pharmacokinetics of TRV734 in Healthy Adult Male and Female Subjects
Status: Enrolling
Updated:  8/6/2014
ICON Development Solutions
mi
from
San Antonio, TX
A Safety, Tolerability, PD and PK Study in Healthy Adults
A Two-Part Study to Evaluate the Safety, Tolerability, Pharmacodynamics And Pharmacokinetics of TRV734 in Healthy Adult Male and Female Subjects
Status: Enrolling
Updated: 8/6/2014
ICON Development Solutions
mi
from
San Antonio, TX
Click here to add this to my saved trials
Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect
A Randomized, Double-Blinded, Placebo-Controlled, Single-Ascending-Dose (SAD) Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect
Status: Enrolling
Updated:  8/7/2014
Clinical Research Facility
mi
from
Evansville, IN
Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect
A Randomized, Double-Blinded, Placebo-Controlled, Single-Ascending-Dose (SAD) Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect
Status: Enrolling
Updated: 8/7/2014
Clinical Research Facility
mi
from
Evansville, IN
Click here to add this to my saved trials
Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect
A Randomized, Double-Blinded, Placebo-Controlled, Single-Ascending-Dose (SAD) Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect
Status: Enrolling
Updated:  8/7/2014
Clinical Research Facility
mi
from
Madison, WI
Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect
A Randomized, Double-Blinded, Placebo-Controlled, Single-Ascending-Dose (SAD) Study of the Safety, Tolerability, and Pharmacokinetics of BIIB061 in Healthy Adult Volunteers Including Absolute Bioavailability and Food Effect
Status: Enrolling
Updated: 8/7/2014
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
Controlled Acute Hypoxia Study - Abbreviated Sensor Line
Controlled Acute Hypoxia Study Comparing Pulse Oximetry to Arterial Blood Samples Using the Abbreviated Sensor Line in Healthy Subjects With the USB Pulse Oximetry Monitor Interface Cable
Status: Enrolling
Updated:  8/12/2014
Boulder Clinical Laboratory
mi
from
Boulder, CO
Controlled Acute Hypoxia Study - Abbreviated Sensor Line
Controlled Acute Hypoxia Study Comparing Pulse Oximetry to Arterial Blood Samples Using the Abbreviated Sensor Line in Healthy Subjects With the USB Pulse Oximetry Monitor Interface Cable
Status: Enrolling
Updated: 8/12/2014
Boulder Clinical Laboratory
mi
from
Boulder, CO
Click here to add this to my saved trials
A Study to Examine the Distribution of PF-06372865 in the Brain of Healthy Volunteers Using Positron Emission Tomography and a Radioactive Tracer Following Oral Administration of One Dose of PF-06372865
A Phase 1, Open-Label Study To Evaluate Central Occupancy Of The Benzodiazepine Binding Site Of Gaba-A Receptors By Positron Emission Tomography (Pet) With Ligand [11c]Flumazenil Following Single Dose Of PF-06372865 In Healthy Subjects
Status: Enrolling
Updated:  8/15/2014
Pfizer Investigational Site
mi
from
New Haven, CT
A Study to Examine the Distribution of PF-06372865 in the Brain of Healthy Volunteers Using Positron Emission Tomography and a Radioactive Tracer Following Oral Administration of One Dose of PF-06372865
A Phase 1, Open-Label Study To Evaluate Central Occupancy Of The Benzodiazepine Binding Site Of Gaba-A Receptors By Positron Emission Tomography (Pet) With Ligand [11c]Flumazenil Following Single Dose Of PF-06372865 In Healthy Subjects
Status: Enrolling
Updated: 8/15/2014
Pfizer Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
A Study to Examine the Distribution of PF-06372865 in the Brain of Healthy Volunteers Using Positron Emission Tomography and a Radioactive Tracer Following Oral Administration of One Dose of PF-06372865
A Phase 1, Open-Label Study To Evaluate Central Occupancy Of The Benzodiazepine Binding Site Of Gaba-A Receptors By Positron Emission Tomography (Pet) With Ligand [11c]Flumazenil Following Single Dose Of PF-06372865 In Healthy Subjects
Status: Enrolling
Updated:  8/15/2014
Pfizer Investigational Site
mi
from
New Haven, CT
A Study to Examine the Distribution of PF-06372865 in the Brain of Healthy Volunteers Using Positron Emission Tomography and a Radioactive Tracer Following Oral Administration of One Dose of PF-06372865
A Phase 1, Open-Label Study To Evaluate Central Occupancy Of The Benzodiazepine Binding Site Of Gaba-A Receptors By Positron Emission Tomography (Pet) With Ligand [11c]Flumazenil Following Single Dose Of PF-06372865 In Healthy Subjects
Status: Enrolling
Updated: 8/15/2014
Pfizer Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials